bluebird bio Inc at Alliance for Regenerative Medicine Cell & Gene Therapy Investor Day Transcript
Next, we have a man that probably doesn't need introduction around these parts: Jeff Walsh, Chief Strategy Officer of bluebird bio.
Yes, we're live. Okay. Thanks. Good afternoon, everybody. I know I'm holding us up from getting to lunch. So hopefully, we can get through this quickly without too many stomachs rumbling.
But it's a really exciting time to be here for us in particular as I think many of you know that we're potentially on the cusp of commercializing our first of -- potentially 4 products.
I'm going to be making some forward-looking statements, so please refer to the SEC filings for more information about the risk of the company.
You know that we as a company have been anchored in the patient for many years, and these are some of the faces that we're very familiar with and that we focus on as we endeavor to bring these therapies to market. The one of the left, I just
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
